Aberdeen Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$4.49M |
| 2 |
Apple
AAPL
|
+$526K |
| 3 |
Nuveen AMT-Free Quality Municipal Income Fund
NEA
|
+$257K |
| 4 |
GE Aerospace
GE
|
+$245K |
| 5 |
Lockheed Martin
LMT
|
+$234K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$300K |
| 2 |
Abbott
ABT
|
+$77.5K |
| 3 |
Deere & Co
DE
|
+$53.2K |
| 4 |
State Street SPDR S&P Dividend ETF
SDY
|
+$45K |
| 5 |
Chevron
CVX
|
+$39.6K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.85% |
| 2 | Technology | 13.55% |
| 3 | Industrials | 10.46% |
| 4 | Consumer Staples | 10.39% |
| 5 | Financials | 7.45% |
Similar funds
Aberdeen Wealth Management's Q4 2022 Portfolio in Review
As of Q4 2022, Aberdeen Wealth Management held 168 positions worth $133M, up 17% from $114M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Aberdeen Wealth Management deployed $6.38M of net new capital in Q4 2022, opening 7 new positions and adding to 30 existing holdings. Its largest new stake was Vanguard Ultra-Short Bond ETF: 91,694 shares worth $4.49M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $300K trimmed.
- Aberdeen Wealth Management's largest Q4 2022 buy was Vanguard Ultra-Short Bond ETF: 91,694 shares worth $4.49M.
- Aberdeen Wealth Management added most to Apple in Q4 2022, an estimated $526K increase.
- Aberdeen Wealth Management's biggest Q4 2022 reduction was AbbVie, cutting an estimated $300K.
- Aberdeen Wealth Management's ten largest holdings make up 32% of its $133M portfolio in Q4 2022.
- Aberdeen Wealth Management opened 7 new positions and closed 0 in Q4 2022.
- Aberdeen Wealth Management's portfolio value rose 17% quarter-over-quarter to $133M.
Based on Aberdeen Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.